Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Promotes early detection and screening for colorectal cancer among Americans.
The problem
Colorectal cancer remains a leading cause of cancer deaths. Early detection through screening significantly improves survival rates and treatment outcomes.
The proposal
Bill likely establishes programs, funding, or requirements to increase colorectal cancer screening access, awareness, and early detection initiatives across the U.S.
The impact
Patients, healthcare providers, insurance companies, and public health programs would be affected through expanded screening requirements, costs, and improved disease detection rates.
Early screening catches colorectal cancer at treatable stages, significantly improving survival rates. Studies show colonoscopies and screening reduce colorectal cancer deaths by 15-30%.
Detecting cancer early prevents more expensive late-stage treatments like chemotherapy and surgery. Early intervention typically costs less than emergency care for advanced cancers.
Legislation promoting screening raises awareness about colorectal cancer risks and prevention. More informed populations take preventive health actions.
Federal programs can help ensure low-income and underserved communities access screening. Reduces health disparities across different populations.
Expanded screening programs require federal funding and budget allocation. Costs could be substantial depending on program scope and implementation.
Widespread screening can detect benign polyps requiring unnecessary procedures. This creates anxiety and extra medical costs for patients without cancer risk.
Increased screening demand may overwhelm existing medical facilities and specialists. Scheduling delays could reduce screening effectiveness in some regions.
Requirements may increase insurance premiums or coverage restrictions. Not all insurance plans may adequately cover new screening mandates.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.